BDF Gestion Sells 923 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

BDF Gestion lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,101 shares of the medical equipment provider's stock after selling 923 shares during the quarter. BDF Gestion's holdings in Intuitive Surgical were worth $3,706,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the company. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth $26,000. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter valued at about $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the third quarter worth about $38,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jamie Samath sold 22,903 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company's stock, valued at $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock valued at $15,357,560 in the last quarter. Company insiders own 0.90% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on ISRG shares. Leerink Partners increased their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday. BTIG Research increased their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research note on Friday, October 18th. Truist Financial lifted their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a report on Friday, January 24th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $7.47 during midday trading on Thursday, reaching $580.18. The stock had a trading volume of 1,959,803 shares, compared to its average volume of 2,014,436. The stock has a market capitalization of $206.65 billion, a P/E ratio of 93.28, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The firm's fifty day simple moving average is $549.32 and its 200-day simple moving average is $507.50. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.